Groupe la Francaise Acquires 5,217 Shares of Agilent Technologies, Inc. $A

Groupe la Francaise lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 15.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,069 shares of the medical research company’s stock after buying an additional 5,217 shares during the period. Groupe la Francaise’s holdings in Agilent Technologies were worth $4,453,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in Agilent Technologies by 4.3% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after purchasing an additional 24,687 shares during the last quarter. CCLA Investment Management raised its stake in Agilent Technologies by 1.9% during the 4th quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock valued at $142,542,000 after buying an additional 19,518 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Agilent Technologies by 13.8% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after buying an additional 1,713,216 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Agilent Technologies by 20.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock valued at $7,269,000 after buying an additional 9,236 shares during the period. Finally, Oak Thistle LLC bought a new position in shares of Agilent Technologies during the 4th quarter valued at $3,457,000.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on A. Royal Bank Of Canada started coverage on Agilent Technologies in a report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective for the company. Barclays increased their target price on Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Robert W. Baird boosted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research note on Tuesday, May 26th. Piper Sandler assumed coverage on Agilent Technologies in a research note on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Finally, TD Cowen increased their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $159.35.

Agilent Technologies Trading Down 0.3%

NYSE:A opened at $138.32 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $39.06 billion, a price-to-earnings ratio of 27.77, a price-to-earnings-growth ratio of 2.46 and a beta of 1.25. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The business has a fifty day moving average price of $132.35 and a 200-day moving average price of $125.30.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The company had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.Agilent Technologies’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the firm earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts forecast that Agilent Technologies, Inc. will post 6.01 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were paid a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.